Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

538 ARTÍCULOS , VIENDO DEL 256 AL 270

Depression and social phobia in essential tremor and Parkinson's disease

Smeltere L, Kuzņecovs V, Erts R.

Brain Behav. 2017 Aug 2;7(9):e00781. doi: 10.1002/brb3.781. eCollection 2017 Sep.

Chronic subdural haematoma presenting as freezing of gait

Noda K, Hattori N, Okuma Y, Yamamoto T.

BMJ Case Rep. 2017 Sep 26;2017:bcr2017221469. doi: 10.1136/bcr-2017-221469.

Caffeine as symptomatic treatment for Parkinson disease (Café-PD): A randomized trial

Postuma RB, Anang J, Pelletier A, Joseph L, Moscovich M, Grimes D, Furtado S, Munhoz RP, Appel-Cresswell S, Moro A, Borys A, Hobson D, Lang AE.

Neurology. 2017 Oct 24;89(17):1795-1803. doi: 10.1212/WNL.0000000000004568. Epub 2017 Sep 27.

The Neuropsychology (Broadly Conceived) of Multiple System Atrophy, Progressive Supranuclear Palsy, and Corticobasal Degeneration

Gerstenecker A.

Arch Clin Neuropsychol. 2017 Nov 1;32(7):861-875. doi: 10.1093/arclin/acx093.

Cognitive and Neuropsychiatric Features in Parkinson's and Lewy Body Dementias

Fields JA.

Arch Clin Neuropsychol. 2017 Nov 1;32(7):786-801. doi: 10.1093/arclin/acx085.

Thoracic surgery in patients with an implanted neurostimulator device

Meyring K, Zehnder A, Schmid RA, Kocher GJ.

Interact Cardiovasc Thorac Surg. 2017 Oct 1;25(4):667-668. doi: 10.1093/icvts/ivx213.

Dysregulated microRNAs in neural system: Implication in pathogenesis and biomarker development in Parkinson's disease

Lu J, Xu Y, Quan Z, Chen Z, Sun Z, Qing H.

Neuroscience. 2017 Dec 4;365:70-82. doi: 10.1016/j.neuroscience.2017.09.033. Epub 2017 Sep 28.

Validation of the Hebrew version of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale

Zitser J, Peretz C, Ber David A, Shabtai H, Ezra A, Kestenbaum M, Brozgol M, Rosenberg A, Herman T, Balash Y, Gadoth A, Thaler A, Stebbins GT, Goetz CG, Tilley BC, Luo ST, Liu Y, Giladi N, Gurevich T.

Parkinsonism Relat Disord. 2017 Dec;45:7-12. doi: 10.1016/j.parkreldis.2017.09.012. Epub 2017 Sep 24.

Cognitive changes in prodromal Parkinson's disease: A review

Fengler S, Liepelt-Scarfone I, Brockmann K, Schäffer E, Berg D, Kalbe E.

Mov Disord. 2017 Dec;32(12):1655-1666. doi: 10.1002/mds.27135. Epub 2017 Oct 5.

Neuroinflammation - A major cause for striatal dopaminergic degeneration in Parkinson's disease

Kaur K, Gill JS, Bansal PK, Deshmukh R.

J Neurol Sci. 2017 Oct 15;381:308-314. doi: 10.1016/j.jns.2017.08.3251. Epub 2017 Aug 26.

The BSSG rat model of Parkinson's disease: progressing towards a valid, predictive model of disease

Van Kampen JM, Robertson HA.

EPMA J. 2017 Sep 4;8(3):261-271. doi: 10.1007/s13167-017-0114-6. eCollection 2017 Sep.

Long-term effects of exercise and physical therapy in people with Parkinson disease

Mak MK, Wong-Yu IS, Shen X, Chung CL.

Nat Rev Neurol. 2017 Nov;13(11):689-703. doi: 10.1038/nrneurol.2017.128. Epub 2017 Oct 13.

Clinical Ethics in the Context of Deep Brain Stimulation for Movement Disorders

Kubu CS, Ford PJ.

Arch Clin Neuropsychol. 2017 Nov 1;32(7):829-839. doi: 10.1093/arclin/acx088.

Levodopa-carbidopa intestinal gel in advanced Parkinson's: Final results of the GLORIA registry

Antonini A, Poewe W, Chaudhuri KR, Jech R, Pickut B, Pirtošek Z, Szasz J, Valldeoriola F, Winkler C, Bergmann L, Yegin A, Onuk K, Barch D, Odin P; GLORIA study co-investigators.

Parkinsonism Relat Disord. 2017 Dec;45:13-20. doi: 10.1016/j.parkreldis.2017.09.018. Epub 2017 Sep 22.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias